Podcast

A Song for Hope

Author(s):

Kristie L. Kahl

Cancer Blows, an event by The Ryan Anthony Foundation, offers hope for many with cancer – all while raising awareness for multiple myeloma.

It was one man’s passion for music that actually led to his multiple myeloma diagnosis.

In 2012, Ryan Anthony received his cancer diagnosis at just 43 years of age — something that was sparked by chronic aches and pains while playing his trumpet.

With this passion, he and fellow musicians created the Cancer Blows event, designed to raise both awareness and money to encourage research for multiple myeloma.

For more information, visit cancerblows.com.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of doctor with grey hair.
Dr. Mikhael in an interview with CURE
Dr. Ajai Chari in an in interview with CURE
An image of Dr. Patel in an interview with CURE discussing healthy lifestyles in myeloma
Dr. Munshi in an interview with CURE
Dr. Dikran Kazandjian during an interview with CURE
Related Content
Bispecific antibodies target specific cells, offering effective treatment for relapsed/refractory multiple myeloma, with varying side effect profiles: © stock.adobe.com
April 4th 2025

Understanding the Use of Bispecific Antibodies in Multiple Myeloma

Ryan Scott
Bispecific antibodies target specific cells, offering effective treatment for relapsed/refractory multiple myeloma, with varying side effect profiles.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Dr. Surbhi Sidana discussed the topic of minimal residual disease: nobeastsofierce - stock.adobe.com
April 1st 2025

What Role Does MRD Play in Multiple Myeloma Treatment Decision Making?

Alex Biese
Dr. Surbhi Sidana discussed the topic of minimal residual disease during the CURE Educated Patient® Multiple Myeloma Summit.
cancer horizons podcast logo: a white microphone on a blue background
March 4th 2024

Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

Alex Biese Brielle Benyon
In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.
Illustration of blood cells.
March 26th 2025

Communication is Key When Transitioning Multiple Myeloma Care

Alex Biese
A panel of experts discussed the transition of care between community and academic centers at the CURE Educated Patient Multiple Myeloma Summit.
Darzalex and Revlimid maintenance improves survival following autologous stem cell transplantation in multiple myeloma: © stock.adobe.com.
March 18th 2025

Darzalex Plus Revlimid Improves Outcomes in Newly Diagnosed Myeloma

Alex Biese
Darzalex and Revlimid maintenance resulted in superior outcomes versus Revlimid alone following autologous stem cell transplantation in multiple myeloma.